Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis

Journal of Immunology

Volumn 156, Issue 4, 1996, Pages 1476-1481

  Hayashi, Seiji ^a   Chan, Chi Chao ^a   Gazzinelli, Ricardo ^b,c   Roberge, François G ^a,b  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; GAMMA INTERFERON; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HOST PARASITE INTERACTION; HOST RESISTANCE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SPLEEN CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CELL SURVIVAL; DINOPROSTONE; FEMALE; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; SPLEEN; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030062328     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Zuber, P., and P. Jacquier. 1995. Epidemiology of toxoplasmosis: worldwide status. Schweiz Med Wochenschr. 125:19.
2. Farkash, A. E., P J. Maccabee, J. H. Sher, S. H. Landesman, and G. Hotson 1986. CNS toxoplasmosis in acquired immune deficiency syndrome a clinical-pathological-radiological review of 12 cases. J Neurol. Neurosurg. Psychiatry 49:744.
3. Luft, B. J., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211.
4. McGregor, C. G. A., D G. Fleck, J Nagington, P. G. I. Stovin, R Cory-Pearce, and T A. H English. 1984. Disseminated toxoplasmosis in cardiac transplantation J. Clin. Pathol. 37:74.
5. Slavin, M. A., J. D. Meyers, J. S. Remington, and R. C. Hackman. 1994. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience Bone Marrow Transplant. 13:549.
6. + T lymphocytes in IFNγ production, and protective immunity induced by an attenuated Toxoplasma gondii vaccine J. Immunol. 146:286.
7. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147:2310
8. Beaman, M H., S. Y. Wong, and J. S. Remington 1992. Cytokines, toxoplasma and intracellular parasitism. Immunol Rev. 127:97.
9. Suzuki, Y., M A. Orellana, R. D. Schreiber, and J. S. Remington 1988 Interferon-γ: the major mediator of resistance against Toxoplasma gondii Science 240.516.
10. Murray, H. W., C. W Juangbhanich, C. F. Nathan, and Z. A. Cohn. 1979 Macrophage oxygen-dependent antimicrobial activity II The role of oxygen intermediates. J. Exp. Med. 150.950.
11. Murray, H. W., and Z. A. Cohn. 1979. Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J. Exp. Med. 150:938.
12. Adams, L. B., J. B. Hibbs, R. R. Taintor, and J. L. Krahenbuhl. 1990 Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. J. Immunol. 144:2725
13. Lowenstein, C. J , and S. H. Snyder. 1992 Nitric oxide, a novel biologic messenger. Cell 70.705
14. Moncada, S., R. M. Palmer, and E. A. Higgs 1991. Nitric oxide physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43:109.
15. Palmer, R. M J., D. S. Ashton, and S. Moncada 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664.
16. Knowles, R. G., M. Palacios, R. M. J. Palmer, and S. Moncada. 1989. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl Acad. Sci. USA 86:5159
17. Hibbs, J J , R. R. Taintor, and Z. Vavrin 1987. Macrophage cytotoxicity. role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235:473.
18. Granger, D. L., J. J. Hibbs, J. R Perfect, and D T Durack. 1988. Specific ammo acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J. Clin. Invest. 81:1129
19. Granger, D. L., J B. Hibbs, Jr., J. R. Perfect, and D. T. Durack 1990. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages J. Clin. Invest. 85 264.
20. Nathan, C F, and J. J. Hibbs. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin Immunol. 3:65.
21. Langermans, J. A., d. H. M. Van, P. II. Nibbering, P S. Hiemstra, L Fransen, and F. R. Van. 1992. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α J. Immunol. 148:568
22. Evans, T. G., L Thai, D. L. Grager, and J. B. Hibbs, Jr. 1993 Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J Immunol 151. 907.
23. Boockvar, K S., D. L. Granger, R. M. Poston, M. Maybodi, M K. Washington, J. B. J. Hibbs, and R L. Kurlander. 1994. Nitric oxide produced during murine listenosis is protective. Infect. Immun. 62:1089.
24. Beckerman, K P., H. W. Rogers, J A. Corbett, R. D. Schreiber, M L. McDaniel, and R. R. Unanue 1993. Release of nitric oxide during the T cell-independent pathway of macrophages activation Its role in resistance to Listeria monocytogenes. J. Immunol. 150:888.
25. Mills, C. D. 1991. Molecular basis of suppressor macrophages Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146:2719
26. Tomioka, T., and H. Saito. 1992. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J. Leukocyte Biol. 51:24.
27. Candolfi, E , C A Hunter, and J. S Remington. 1994. Mitogen and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect. Immun. 62:1995.
28. Stout, R. D., K. P. Ferguson, Y. N. Li, and D J. Lambe. 1992. Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production. Infect. Immun. 60:922.
29. Schleifer, K. W., and J. M. Mansfield 1993. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151:5492.
30. Corbett, J. A., A. Mikhael, J. Shimizu, K Frederick, T. P. Misko, M. M. L., O. Kanagawa, and E. R. Unanue. 1993. Nitric oxide production in islets from nonobese diabetic mice: ammoguanidine-sensitive and resistant stages in the immunological diabetic process Proc Natl. Acad Sci. USA 90:8992
31. Misko, T. P., W M. Moore, T P. Kasten, G. A Nickols, J A. Corbett, R G Tilton, M. L. McDaniel, J. R. Williamson, and M. G. Currie. 1993. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine Eur J. Pharmacol. 233:119.
32. Gazzinelli, R. T., I. Eltoum, T. A. Wynn, and A. Sher. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducibie nitric oxide synthase and other markers of macrophage activation J. Immunol. 151:3672.
33. Gazzinelli, R., Y. Xu, S. Hieny, A. Cheever, and A. Sher. 1992. Simultaneous depletion of CD4 and CD8 T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol 149:175
34. Mosmann, T 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55
35. Ding, A H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages Comparison of activating cytokines and evidence for independent production J. Immunol. 141:2407
36. Miltenyi, S . W Mutler, W. Weichel, and A Radbruch. 1990. High gradient magnetic cell separation with MACS. Cytometry 11 231.
37. Sarih, M., V. Souvannavong, and A. Adam. 1993. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys Res. Commun. 191.503
38. Albina, J. E., S Cui, R. B. Mateo, and J. S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150.5080.
39. 2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells. Eur. J. Immunol. 18:1791.
40. 2. J. Immunol. 145.2616
41. Gaillard, T., A. Mulsch, H. Klein, and K. Decker. 1992. Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem. Hoppe-Seyler 373:897.
42. Sowa, G., and R Przewlocki. 1994. cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures. Eur. J. Pharmacol. 266:125.
43. Imai, T., Y Hirata, K Kanno, and F. Marumo. 1994. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J Clin. Invest. 93:143
44. Shirahata, T , and K. Shimizu 1982. Growth inhibition of Toxoplasma gondii in cell cultures treated with murine type II interferon Jpn. J. Vet Sci. 44:865.
45. Suzuki, Y., F. K. Conley, and J. S Remington 1989. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J Immunol. 143:2045
46. Sibley, L. D , L. D. Adams, Y. Fukutomi, and J. L. Krahenbuhl. 1991. Tumor necrosis factor-α triggers antitoxoplasmal activity of IFN-γ primed macrophages. J Immunol. 147.2340.
47. Gazzinelli, R T., A. Brezin, Q. Li, R. B. Nussenblatt, and C C. Chan. 1994. Toxoplasma gondii acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ Exp. Parasitol. 78:217.
48. Tao, X., and R. D. Stout. 1993. T cell-mediated cognate signaling of nitric oxide production by macrophages: requirements for macrophage activation by plasma membranes isolated from T cells. Eur. J Immunol. 23:2916